J. Dahlman
Biomedical Engineering · 2011–2022
A researcher in the Science corpus: 4 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Biomedical Engineering — 34 citations into it
Whom J. Dahlman trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from J. Dahlman's perspective
Ordered by how strongly the researchers J. Dahlman trusts endorse each paper. Same corpus, a different order for every researcher.
- The Streptococcus thermophilus CRISPR/Cas system provides immunity in Escherichia coli (Nucleic Acids Research)
- CRISPR Provides Acquired Resistance Against Viruses in Prokaryotes (Science)
- Genetic Screens in Human Cells Using the CRISPR-Cas9 System (Science)
- The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA (Nature)
- Optical Control of Mammalian Endogenous Transcription and Epigenetic States (Nature)
- A combinatorial library of lipid-like materials for delivery of RNAi therapeutics (Nature Biotechnology)
- Cas9–crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria (Proceedings of the National Academy of Sciences of the United States of America)
- High-throughput screening of a CRISPR/Cas9 library for functional genomics in human cells (Nature)
- Genome-wide recessive genetic screening in mammalian cells with a lentiviral CRISPR-guide RNA library (Nature Biotechnology)
- Enhancing Gene Targeting with Designed Zinc Finger Nucleases (Science)
Their papers
- CRISPR-Cas9 Knockin Mice for Genome Editing and Cancer Modeling (2014) — 1,875 citations
- Treating metastatic cancer with nanotechnology (2011) — 1,116 citations
- Drug delivery systems for RNA therapeutics (2022) — 1,042 citations
- Emerging Frontiers in Drug Delivery. (2016) — 710 citations